Thoracic positron emission tomography: ¹⁸F-fluorodeoxyglucose and beyond.

ABSTRACT: Ongoing technologic and therapeutic advancements in medicine are now testing the limits of conventional anatomic imaging techniques. The ability to image physiology, rather than simply anatomy, is critical in the management of multiple disease processes, especially in oncology. Nuclear medicine has assumed a leading role in detecting, diagnosing, staging and assessing treatment response of various pathologic entities, and appears well positioned to do so into the future. When combined with computed tomography (CT) or magnetic resonance imaging (MRI), positron emission tomography (PET) has become the sine quo non technique of evaluating most solid tumors especially in the thorax. PET/CT serves as a key imaging modality in the initial evaluation of pulmonary nodules, often obviating t

SUBMITTER: Jaykel TJ 

PROVIDER: S-EPMC7711422 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature